Clinical Trial Update: Effects of a Nutraceutic Compound on Cognitive Impairment [Phase 4]

View source ↗

Summary

Phase 4 trial update on a nutraceutical compound for cognitive impairment in individuals with mild cognitive impairment.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cognitive Impairment

Drugs mentioned

• Nutraceutic Compound

Snippet

Sponsor: Federico II University | Conditions: Mild Cognitive Impairment | Phase 4 | Status: COMPLETED